- Ublituximab
- Umbralisib
According to the NCI website, ublituximab is a chimeric recombinant IgG1 monoclonal antibody directed against human CD20 with potential antineoplastic activity. Check for active clinical trials using this agent. (NCI Thesaurus)
More Information in English:
Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute
According to the NCI website, umbralisib is an orally bioavailable, selective inhibitor of the delta isoform of the 110 kDa catalytic subunit of class I phosphoinositide-3 kinases (PI3K) with potential antineoplastic activity. Check for active clinical trials using this agent. (NCI Thesaurus)
More Information in English:
Link to MedlinePlus, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute